Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy.

Shujie Huang,Yong Tang,Hansheng Wu,Qiuling Shi,Jiming Tang,Xiaosong Ben,Dongkun Zhang,Liang Xie,Haiyu Zhou,Gang Chen,Sichao Wang,Zhen Gao,Zefeng Xie,Rixin Chen,Guibin Qiao

Annals of surgical oncology（2023）

引用 1|浏览14

暂无评分

摘要

The current study demonstrated that a longitudinal patient-reported outcome (PRO) was an easily obtained, cost-effective, and noninvasive tool for predicting tumor responses to neoadjuvant immunochemotherapy.

查看译文

关键词

esophageal squamous cell carcinoma,dysphagia,esophageal squamous cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要